Sionna Therapeutics (SION) Competitors $17.11 -0.15 (-0.87%) As of 02:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SION vs. IMVT, HCM, IBRX, AAPG, APLS, OGN, XENE, ARWR, AMRX, and MIRMShould you be buying Sionna Therapeutics stock or one of its competitors? The main competitors of Sionna Therapeutics include Immunovant (IMVT), HUTCHMED (HCM), ImmunityBio (IBRX), Ascentage Pharma Group International (AAPG), Apellis Pharmaceuticals (APLS), Organon & Co. (OGN), Xenon Pharmaceuticals (XENE), Arrowhead Pharmaceuticals (ARWR), Amneal Pharmaceuticals (AMRX), and Mirum Pharmaceuticals (MIRM). These companies are all part of the "pharmaceutical products" industry. Sionna Therapeutics vs. Its Competitors Immunovant HUTCHMED ImmunityBio Ascentage Pharma Group International Apellis Pharmaceuticals Organon & Co. Xenon Pharmaceuticals Arrowhead Pharmaceuticals Amneal Pharmaceuticals Mirum Pharmaceuticals Immunovant (NASDAQ:IMVT) and Sionna Therapeutics (NASDAQ:SION) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment. Does the MarketBeat Community believe in IMVT or SION? Immunovant received 129 more outperform votes than Sionna Therapeutics when rated by MarketBeat users. Likewise, 77.19% of users gave Immunovant an outperform vote while only 75.00% of users gave Sionna Therapeutics an outperform vote. CompanyUnderperformOutperformImmunovantOutperform Votes13277.19% Underperform Votes3922.81% Sionna TherapeuticsOutperform Votes375.00% Underperform Votes125.00% Does the media favor IMVT or SION? In the previous week, Immunovant had 1 more articles in the media than Sionna Therapeutics. MarketBeat recorded 8 mentions for Immunovant and 7 mentions for Sionna Therapeutics. Immunovant's average media sentiment score of 1.30 beat Sionna Therapeutics' score of 0.74 indicating that Immunovant is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Immunovant 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sionna Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate IMVT or SION? Immunovant currently has a consensus price target of $38.33, suggesting a potential upside of 136.19%. Sionna Therapeutics has a consensus price target of $38.50, suggesting a potential upside of 125.01%. Given Immunovant's higher possible upside, equities analysts clearly believe Immunovant is more favorable than Sionna Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Immunovant 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.90Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in IMVT or SION? 47.1% of Immunovant shares are owned by institutional investors. 5.9% of Immunovant shares are owned by company insiders. Comparatively, 3.9% of Sionna Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is IMVT or SION more profitable? Sionna Therapeutics' return on equity of 0.00% beat Immunovant's return on equity.Company Net Margins Return on Equity Return on Assets ImmunovantN/A -77.94% -69.82% Sionna Therapeutics N/A N/A N/A Which has stronger earnings & valuation, IMVT or SION? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunovantN/AN/A-$259.34M-$2.74-5.92Sionna TherapeuticsN/AN/AN/AN/AN/A SummaryImmunovant beats Sionna Therapeutics on 9 of the 12 factors compared between the two stocks. Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SION and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SION vs. The Competition Export to ExcelMetricSionna TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$754.96M$6.93B$5.60B$8.63BDividend YieldN/A2.55%5.28%4.18%P/E RatioN/A8.8727.2520.01Price / SalesN/A263.25412.71157.94Price / CashN/A65.8538.2534.64Price / BookN/A6.617.124.70Net IncomeN/A$144.20M$3.24B$248.05M7 Day Performance6.74%3.88%2.75%2.62%1 Month Performance32.64%11.26%9.00%6.32%1 Year PerformanceN/A3.96%31.41%13.78% Sionna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIONSionna TherapeuticsN/A$17.11-0.9%$38.50+125.0%N/A$754.96MN/A0.0035IMVTImmunovant1.5791 of 5 stars$15.67+2.2%$38.33+144.6%-35.7%$2.67BN/A-5.97120Positive NewsAnalyst RevisionHCMHUTCHMED0.8558 of 5 stars$15.23-0.5%$19.00+24.8%-4.2%$2.65B$630.20M0.001,760Upcoming EarningsIBRXImmunityBio2.3589 of 5 stars$2.95+0.5%$12.25+316.0%-45.6%$2.61B$31.22M-3.21590AAPGAscentage Pharma Group InternationalN/A$28.29+1.9%N/AN/A$2.46B$980.65M0.00600Gap UpAPLSApellis Pharmaceuticals4.7648 of 5 stars$19.35+4.5%$40.05+107.0%-54.9%$2.43B$775.84M-9.52770Positive NewsAnalyst RevisionOGNOrganon & Co.4.7983 of 5 stars$9.24-3.1%$18.00+94.9%-50.1%$2.40B$6.29B2.7710,000Trending NewsXENEXenon Pharmaceuticals3.6794 of 5 stars$30.79+1.1%$54.82+78.1%-15.0%$2.36B$7.50M-10.92210Options VolumeAnalyst RevisionARWRArrowhead Pharmaceuticals3.6107 of 5 stars$16.65-0.6%$43.71+162.6%-32.1%$2.30B$545.21M-3.21400Analyst RevisionAMRXAmneal Pharmaceuticals3.7315 of 5 stars$7.20-0.2%$11.50+59.8%+10.7%$2.26B$2.83B-10.587,600Positive NewsMIRMMirum Pharmaceuticals3.2206 of 5 stars$44.62+0.0%$60.73+36.1%+85.0%$2.21B$379.25M-22.09140Positive NewsAnalyst Revision Related Companies and Tools Related Companies IMVT Alternatives HCM Alternatives IBRX Alternatives AAPG Alternatives APLS Alternatives OGN Alternatives XENE Alternatives ARWR Alternatives AMRX Alternatives MIRM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SION) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SION Stock Free SION Stock Alerts